Workflow
Over-the-Counter (OTC) Pharmaceuticals
icon
Search documents
Perrigo(PRGO) - 2025 Q2 - Earnings Call Transcript
2025-08-06 13:32
Perrigo Company (PRGO) Q2 2025 Earnings Call August 06, 2025 08:30 AM ET Company ParticipantsBradley Joseph - VP - Global IR & Corporate CommunicationsPatrick Taylor - President & CEOEduardo Bezerra - EVP & CFOKeith D - Vice PresidentConference Call ParticipantsSusan Anderson - MD & Senior AnalystEthan Brown - Equity Research AnalystOperatorWelcome to Perrigo Q2 twenty twenty five Financial Results Conference Call. This call is being recorded on Wednesday, 08/06/2025. I would now like to turn the conference ...
Perrigo(PRGO) - 2025 Q2 - Earnings Call Transcript
2025-08-06 13:30
Perrigo Company (PRGO) Q2 2025 Earnings Call August 06, 2025 08:30 AM ET Speaker0Welcome to Perrigo Q2 twenty twenty five Financial Results Conference Call. This call is being recorded on Wednesday, 08/06/2025. I would now like to turn the conference over to Bradley Joseph. Please go ahead.Speaker1Good morning and good afternoon, everyone. Welcome to Perrigo's second quarter twenty twenty five earnings conference call. I hope you all had a chance to review our press release issued today. A copy of the relea ...
Perrigo(PRGO) - 2025 Q1 - Earnings Call Presentation
2025-05-07 12:36
Q1 2025 Earnings Presentation May 7, 2025 Bradley Joseph VP Investor Relations & Corporate Communications Forward-Looking Statements Certain statements in this presentation are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or ...